Invitation to the presentation of BICO's Interim report Q2 2026
BICO’s Interim report 2026 will be published on Wednesday August 19, 2026, at 07:00am CEST. Following the release of the interim report, a telephone conference with the opportunity to ask questions will be held in English at 10:00 am CEST on the same day, with President & CEO Maria Forss and CFO Ewa Linsäter presenting the interim report.
Information about the presentation and webcast
The presentation will be available on BICO’s website from 09:00am CEST.
https://bico.com/investors/
If you wish to participate via webcast, please use the link below: https://bico.events.inderes.com/q2-report-2026/register
If you wish to participate via teleconference, please register via the link below. After registration you will be provided with phone numbers and a conference ID to access the conference. You can ask questions verbally via teleconference.
https://events.inderes.com/bico/q2-report-2026/dial-in
For further information, please contact:
Ewa Linsäter, Chief Financial Officer, BICO Group AB
Phone: +46 766 33 32 33
E-mail: ewa.linsater@bico.com
About BICO
BICO leverages a global portfolio of pioneering brands fusing automation, intelligence, and data to unlock scientific discovery at scale in pharma and biotech. With 53,600+ instruments installed in over 65 countries, BICO products, software, and solutions are found in more than 3,500 laboratories, including the world’s top 20 pharmaceutical companies, and have been cited in over 13,000 publications. BICO strives towards the vision to enable life-science labs to accelerate the discoveries that change lives. BICO is listed on Mid-Cap, Nasdaq Stockholm under BICO. www.bico.com